MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.877
+0.004 (0.40%)
At close: Apr 28, 2026, 4:00 PM EDT
0.895
+0.018 (2.00%)
After-hours: Apr 28, 2026, 7:27 PM EDT
MaxCyte Employees
MaxCyte had 91 employees as of December 31, 2025. The number of employees decreased by 23 or -20.18% compared to the previous year.
Employees
91
Change (1Y)
-23
Growth (1Y)
-20.18%
Revenue / Employee
$362,923
Profits / Employee
-$490,440
Market Cap
93.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 658 |
| Treace Medical Concepts | 450 |
| Outset Medical | 310 |
| Xtant Medical Holdings | 232 |
| Rapid Micro Biosystems | 171 |
| Nano-X Imaging | 165 |
| Baird Medical Investment Holdings | 143 |
| Hyperfine | 102 |
MXCT News
- 4 weeks ago - MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - MaxCyte Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance - GlobeNewsWire
- 5 weeks ago - MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer - GlobeNewsWire
- 2 months ago - MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery - GlobeNewsWire
- 2 months ago - MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - GlobeNewsWire
- 3 months ago - MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 months ago - Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO - Business Wire